Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Celcuity Inc. amended credit facility of up to $75.0 million with Innovatus Life Sciences Lending Fund I, L.P..
- Instrument
- credit facility
- Principal
- up to $75.0 million
- Counterparty
- Innovatus Life Sciences Lending Fund I, L.P.
- Event
- amendment
Exact text from the filing
Amendment, shall be collectively referred to herein as the “Amended Loan Agreement”). As previously disclosed, the Amended Loan Agreement may provide the Company with up to $75.0 million through funding of up to five term loans. Funding of the first $15.0 million term loan occurred on April 8, 2021 in connection with entering into the original Loan
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Celcuity Inc. amended Second Amendment with Innovatus Life Sciences Lending Fund I, L.P. (effective 2024-03-29).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- Innovatus Life Sciences Lending Fund I, L.P.
- Effective
- 2024-03-29
Exact text from the filing
On March 29, 2024, Celcuity Inc. (the “Company”) entered into a Second Amendment (the “Second Amendment”) to its existing Loan and Security Agreement (the “Loan Agreement”), dated April 8, 2021, between the Company and Innovatus Life Sciences Lending Fund I, L.P., a Delaware limited partnership (“Innovatus")
View on SEC.gov